Gilman’s startup, Arrakis, had a radical solution. It would skip the protein. Instead, the startup — which derives its name from the frontier planet in Dune, source of life-extending ...
CEO Michael Gilman said Arrakis faced an “unbelievable amount of skepticism” when it got started around 2017. In an interview with the Business Journal, Gilman explains how the company charted ...